FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Chronic Kidney Disease

Interventions

DRUG

Finerenone (BAY 94-8862)

Finerenone 10 or 20mg in participants with chronic kidney disease not using renin-angiotensin-system inhibitors

DRUG

Placebo

Placebo matching finerenone

All Listed Sponsors

lead

University Medical Center Groningen

OTHER